Provided by Tiger Fintech (Singapore) Pte. Ltd.

Foot Locker

11.54
+0.09000.79%
Volume:2.76M
Turnover:31.92M
Market Cap:1.10B
PE:91.36
High:11.82
Open:11.60
Low:11.38
Close:11.45
Loading ...

Press Release: Innate Pharma Reports Full Year 2024 Financial Results and Business Update

Dow Jones
·
27 Mar

Foot Locker, Inc. Names Franklin R. Bracken As President

Reuters
·
26 Mar

Foot Locker Names Franklin Bracken as President

MT Newswires Live
·
26 Mar

Foot Locker, Inc. Names Franklin R. Bracken as President

THOMSON REUTERS
·
26 Mar

Press Release: FOOT LOCKER, INC. NAMES FRANKLIN R. BRACKEN AS PRESIDENT

Dow Jones
·
26 Mar

Foot Locker, Inc.'s (NYSE:FL) Share Price Could Signal Some Risk

Simply Wall St.
·
26 Mar

Hutchmed's Tazemetostat Gets Conditional Approval in China for Follicular Lymphoma Treatment

MT Newswires Live
·
24 Mar

Nike’s Q3 results could weigh on Foot Locker near-term, says Jefferies

TipRanks
·
22 Mar

Correction to Foot Locker Headline on March 5

Dow Jones
·
22 Mar

Jefferies Reaffirms Their Hold Rating on Foot Locker (FL)

TIPRANKS
·
21 Mar

Nike's Discounts Could Weigh on Foot Locker's Near-Term Performance -- Market Talk

Dow Jones
·
21 Mar

PREVIEW-Nike to post worst revenue fall in 5 years on stagnant demand

Reuters
·
20 Mar

Calculating The Fair Value Of Foot Locker, Inc. (NYSE:FL)

Simply Wall St.
·
20 Mar

Designer Brands (DBI) To Report Earnings Tomorrow: Here Is What To Expect

StockStory
·
19 Mar

Nipocalimab, the first and only investigational treatment to be granted U.S. FDA Breakthrough Therapy designation for the treatment of adults with moderate-to-severe Sjögren's disease, has now received Fast Track designation

PR Newswire
·
18 Mar

Storm Recovery: U-Haul Offers 30 Days Free Storage at 366 Centers

Business Wire
·
16 Mar

Bristol Myers Squibb Receives Approval from the European Commission to Expand Use of CAR T Cell Therapy Breyanzi for Relapsed or Refractory Follicular Lymphoma

Business Wire
·
14 Mar

Is Foot Locker (FL) Among the Best Apparel Stocks to Invest In?

Insider Monkey
·
10 Mar

Inflation and tariffs might scare shoppers. Have they scared CEOs?

Dow Jones
·
09 Mar

J.P. Morgan Remains a Sell on Foot Locker (FL)

TIPRANKS
·
08 Mar